Neurology® Podcast cover image

Dual Antiplatelet Therapy vs Alteplase for Patients With Acute Ischemic Stroke

Neurology® Podcast

00:00

Introduction

Neurology podcast provides practical information to neurologists and other clinicians. Outcomes for patients with NMDA receptor encephalitis have not changed over the last decade. NIH sponsored extinguish trial is now enrolling new NMDA receptorEncephalitis patients. Tan Nguyen from Boston University talks about her paper titled Dual Antiplate with Therapy versus All to Plays for Patients with Non-Disabling Acute Aschemic Stroke.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app